NIP
GH icon

Nicholas Investment Partners’s Guardant Health GH Stock Holding History

Nicholas Investment Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.09M Sell
11,786
-86,430
-88% -$8.68M 0.08% 178
2025
Q4 		$10M Buy
98,216
+14,310
+17% +$1.28M 0.73% 48
2025
Q3 		$5.24M Sell
83,906
-119,124
-59% -$6.48M 0.4% 90
2025
Q2 		$10.6M Sell
203,030
-31,607
-13% -$1.41M 0.94% 22
2025
Q1 		$10M Buy
+234,637
New +$10.1M 1.03% 22
2022
Q2 		– Sell
-170,198
Closed -$11.3M – 188
2022
Q1 		$11.3M Buy
170,198
+57,985
+52% +$3.97M 0.8% 43
2021
Q4 		$11.2M Buy
112,213
+17,850
+19% +$1.85M 0.71% 52
2021
Q3 		$11.8M Sell
94,363
-32,860
-26% -$3.9M 0.86% 44
2021
Q2 		$15.8M Sell
127,223
-27,284
-18% -$3.67M 0.99% 35
2021
Q1 		$23.6M Buy
154,507
+2,459
+2% +$372K 1.64% 7
2020
Q4 		$19.6M Buy
152,048
+13,948
+10% +$1.6M 1.51% 20
2020
Q3 		$15.4M Buy
138,100
+122,113
+764% +$11.2M 1.67% 18
2020
Q2 		$1.3M Sell
15,987
-26,609
-62% -$2.14M 0.26% 127
2020
Q1 		$2.96M Buy
42,596
+358
+0.8% +$27.5K 0.58% 72
2019
Q4 		$3.3M Sell
42,238
-51,434
-55% -$3.71M 0.34% 100
2019
Q3 		$5.98M Sell
93,672
-244
-0.3% -$21.5K 0.5% 67
2019
Q2 		$8.11M Buy
+93,916
New +$7.17M 0.74% 37

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nicholas Investment Partners's GH Position: Q1 2026 in Review

Nicholas Investment Partners reduced its Guardant Health (GH) stake by 88% in Q1 2026, selling an estimated $8.68M and leaving 11,786 shares worth $1.09M. The position accounts for 0.08% of the portfolio, ranked #178.

Nicholas Investment Partners first reported a position in GH in Q2 2019 and has held it in 17 quarters since. The position peaked at $23.6M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Nicholas Investment Partners held 11,786 shares of Guardant Health worth $1.09M as of Q1 2026.
  • Nicholas Investment Partners sold 86,430 Guardant Health shares in Q1 2026, an estimated $8.68M.
  • Guardant Health made up 0.08% of Nicholas Investment Partners's portfolio in Q1 2026, its #178 holding.
  • Nicholas Investment Partners first reported a position in Guardant Health in Q2 2019 and has held it in 17 quarters since.
  • Nicholas Investment Partners's Guardant Health position peaked at $23.6M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Nicholas Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.